Back to Test Catalogue

Factor H Antibodies, Plasma

Test ID: AFHA P

Test

Aliases/Synonyms

Anti-Factor H Antibodies; anti-CFH; Complement Factor H Ab

Method

ELISA

Report Includes

Factor H Antibodies

Specimens

Plasma

Clinical Utility

Atypical hemolytic uremic syndrome (aHUS) is an inherited or acquired thrombotic microangiopathy (TMA) caused by dysregulated activation of the alternate pathway of the complement system.Factor H (FH) negatively regulates the alternate complement pathway.A loss of FH function by mutation or under the action of an inhibitor (auto-antibody) is associated with the onset of aHUS.The anti-FH antibody assay by ELISA confirms or invalidates a diagnosis of acquired aHUS due to the presence of anti-FH antibodies.

Test Location

QC, CA

Test Version

15-Dec-2022

Specimen

Specimens

Plasma

Collection Containers

Blue top (3.2% buffered citrate)

Sample Volume

2 mL

Minimum Volume

2 mL

Collection & Handling

Handling Information

Prepare platelet-poor plasma and freeze immediately. Store and send frozen.

Stability

Frozen Frozen

Rejection Criteria

Specimen Serum

Test Version

15-Dec-2022

Performance / Interpretation

Method

ELISA

Turnaround Time

1 month

Results

Name Units Reference Range Conversion Factor
Factor H Antibodies Titer

Test Location

QC, CA

Test Version

15-Dec-2022

Interface / Setup

HL7 Interface Codes

Order Code Result Codes Units
AFHA P 64717Anti-Factor H titre

Test Version

15-Dec-2022